Clinical Trial Update: Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating selective versus universal antibiotics for preterm neonates with sepsis risk factors; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Early-onset Neonatal Sepsis
• Preterm Birth
• Preterm Premature Rupture of Membrane
• Sepsis

Snippet

Sponsor: Indian Council of Medical Research | Conditions: Sepsis, PROM, Preterm (Pregnancy) | Phase 3 | Status: NOT_YET_RECRUITING